Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2008
04/10/2008WO2008042174A2 Mesenchymal stem cells and uses therefor
04/10/2008WO2008041914A1 5-(2-AMINO-L-HYDROXYETHYL)-8-HYDROXY-2-OXOQUINOLINE DERIVATIVES AND OTHER COMPOUNDS AS β2 -ADRENERGIC AGONISTS
04/10/2008WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use
04/10/2008WO2008041095A1 Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists
04/10/2008WO2008040967A1 Treatment of fibrosis
04/10/2008WO2008040236A1 Flavones derivatives, preparation methods and uses thereof
04/10/2008WO2007130785A3 Materials and methods for treating pneumocystis pneumonia
04/10/2008WO2007118996A3 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis
04/10/2008US20080086000 Prostaglandin reductase
04/10/2008US20080085909 Protein kinase C (PKC); rheumatoid arthritis, lupus, transplant rejection, asthma, inflammatory bowel disease, cancer and diabetes; for example, 2-(pyrrolidin-3-ylmethylamino)-9-(2-trifluoromethoxybenzyl)-7,8-dihydro-9H-purin-8-one
04/10/2008US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example
04/10/2008US20080085891 Asthma and allergic inflammation modulators
04/10/2008US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof
04/10/2008US20080085313 Administering an endothelin antagonist such as sitaxsentan; freeze drying
04/10/2008CA2665385A1 Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists
04/10/2008CA2665141A1 Composition comprising crustacean gastrolith components and its use
04/10/2008CA2664621A1 Pyrazine-2-carboxamide derivatives
04/09/2008EP1908781A2 Modulation of immune response and methods based thereon
04/09/2008EP1908765A1 Thienopyrimidine derivative
04/09/2008EP1908753A1 Novel heterocyclidene acetamide derivative
04/09/2008EP1908480A1 Interferon- alpha regulator
04/09/2008EP1908473A1 Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli
04/09/2008EP1908468A1 Aerosol formula for inhalation containing an anticholinergic agent
04/09/2008EP1907399A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
04/09/2008EP1907362A1 Amide derivatives as kinase inhibitors
04/09/2008EP1907361A1 Amide derivatives as kinase inhibitors
04/09/2008EP1906960A1 New combination 1
04/09/2008EP1906944A1 Schisandrin b preparation
04/09/2008EP1592671B1 N-substituted (benzoimidazole-2-yl) phenyl amines, method for their production, their use as a medicament or diagnostic agent and medicament containing said substances
04/09/2008EP1450796B1 Benzothiazole derivatives
04/09/2008EP1442114B1 Bacterium causing poultry disease and vaccine derived therefrom
04/09/2008EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
04/09/2008EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
04/09/2008EP1276467B1 Guaifenesin sustained release formulation and tablets
04/09/2008EP1140964B1 Connective tissue growth factor (ctgf) fragment
04/09/2008EP1036175B1 Human brain derived kcnq2 potassium channel
04/09/2008CN201044823Y Medicine label for treating deficiency and excess heterogeneous type slow branch acupoint
04/09/2008CN101160528A Use of il-17f in diagnosis and therapy of airway inflammation
04/09/2008CN101160290A 7-membered ring compound, process for producing the same, and medicinal use thereof
04/09/2008CN101160135A Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
04/09/2008CN101156942A Medicine combination for treating relapse stomatocace and chronic pharyngitis
04/09/2008CN101156923A Health care wine
04/09/2008CN101156889A Application of east purple common perilla extractive
04/09/2008CN101156887A Emblic cotyledon preparation with pulmonary emphysema against function
04/09/2008CN101156871A Ocean deep water nose drops
04/09/2008CN101156860A Use of mometasone furoate for treating airway passage and lung diseases
04/09/2008CN101156712A Perfume additive for natural tobacco and method for making same
04/09/2008CN101156636A A seal wort and lily pure and fresh tea
04/09/2008CN100379869C Super antigen fusion protein and its application method
04/09/2008CN100379758C Streptococcus pneumoniae antigens
04/09/2008CN100379737C Thioxanthine derivatives as myeloperoxidase inhibitors
04/09/2008CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
04/09/2008CN100379734C Azaindoles
04/09/2008CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
04/09/2008CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives
04/09/2008CN100379446C Erythropoietin ameliorates chemotheapy-induced toxicity in vivo
04/09/2008CN100379438C Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation method
04/09/2008CN100379417C Application of sophocarpine in use of making medicines
04/08/2008US7355054 Indole derivatives
04/08/2008US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto
04/08/2008US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
04/08/2008US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12
04/08/2008US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease
04/08/2008US7354931 Treating obstructive airway disorders using nontoxic drug
04/08/2008US7354919 Isoxazole compositions useful as inhibitors of ERK
04/08/2008US7354913 High storage stability inhalable compositions
04/08/2008US7354585 Methods of treating coagulapathic or thrombotic disorders
04/08/2008CA2372962C Novel interleukin-1 and tumor necrosis factor-.alpha. modulators, syntheses of said modulators and methods of using said modulators
04/08/2008CA2304819C Perforated microparticles and methods of use
04/08/2008CA2271126C Method of treating bronchitis with uridine triphosphates and related compounds
04/08/2008CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors
04/03/2008WO2008040002A2 Methods, compositions and articles of manufacture for hif modulating compounds
04/03/2008WO2008039987A2 Methods of treating pulmonary distress
04/03/2008WO2008039139A1 Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy
04/03/2008WO2008039138A1 Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derivatives and their use in therapy
04/03/2008WO2008038711A1 Oxepin derivative
04/03/2008WO2008038692A1 Diaryl ketimine derivative
04/03/2008WO2008037938A1 Ionic hypertonic solutions based on undiluted seawater, their use as pharmaceutical compositions or medication and for preparing medication intended for treating nasal congestion
04/03/2008WO2008037037A2 Anti-asthmatic medicine comprising i. a. caffeine, ergotamine, zinc, papaverine, atropine, aminophyyline, glaucine etc.
04/03/2008WO2008014570A3 Treatment and prevention of allergic airways diseases
04/03/2008WO2007112052A3 Formulations and methods for vascular permeability-related diseases or conditions
04/03/2008WO2007102446A3 Method and composition for treating chronic obstructive pulmonary disease
04/03/2008WO2007098189A3 New crystal forms and pharmaceutical compositions of (+) -r-zileuton
04/03/2008US20080081828 Agent for Curing Chronic Obstructive Pulmonary Disease
04/03/2008US20080081827 administering rimonabant or N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide; cannabinoid receptor antagonist for respiratory system disorders
04/03/2008US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases
04/03/2008US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain
04/03/2008US20080081793 Oligonucleotide Compositions and Their Use to Induce Apoptosis
04/03/2008US20080081788 reduce the elevated level of free IgE in patient's serum by oral administering peptide biodrug; also can reduce nerve growth factor, myoglobin, Insulin, adenosine deaminase; treating asthma, type 2 diabetes, depression, autoimmune diseases, diabetes, Graves' disease, Addison's disease, Hodgkin's disease
04/03/2008US20080081786 Cytokine protein family
04/03/2008US20080081050 Vaccine against streptococcus pneumoniae
04/03/2008CA2664930A1 Novel 5,7-disubstituted[1,3]thiazolo[4,5-d]pyrimidin-2(3h)-amine derivatives and their use in therapy
04/03/2008CA2664789A1 5,7-disubstituted[1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives for the selective inhibtion of chemokine receptors
04/03/2008CA2664358A1 Diarylketimine derivative
04/03/2008CA2664345A1 Oxepin derivative
04/02/2008EP1905834A2 Virulence Genes, Proteins, and their Use
04/02/2008EP1905831A2 Lactoferrin receptor genes of moraxella
04/02/2008EP1905771A2 Quinuclidine derivatives and their use
04/02/2008EP1905763A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
04/02/2008EP1905762A1 Pyrazolone derivative